| 25/418 |
Oncology Breast Cancer |
| 25/417 |
Consultant Posts |
| 25/416 |
Translation and Interpretation Costs |
| 25/415 |
Dravet syndrome and Lennox-Gastaut syndrome |
| 25/414 |
Cyber Security Incidents and Measures (FY22–FY25) |
| 25/413 |
Pancreatic Enzyme Replacement Therapy (PERT) |
| 25/412 |
Internet Connections |
| 25/411 |
Cellular Pathology Services [Histology] |
| 25/410 |
Agency Spend April 2025 |
| 25/408 |
Treatment of Breast Cancer |
| 25/407 |
Radiology Equipment |
| 25/406 |
Curosurf and Peyona |
| 25/405 |
Treatment of Insomnia |
| 25/403 |
Compliance with the Homelessness Reduction Act 2017 |
| 25/402 |
Audited Accounts |
| 25/401 |
Total Knee Replacements |
| 25/400 |
Use of Insourcing for Pathology Services (Haematology, Histopathology, Microbiology) |
| 25/399 |
Scammers and Fraudsters |
| 25/395 |
Ketamine Attendances at A&E |
| 25/393 |
Workforce Systems |
